Report Detail
Global Hypertension Drug Market Insights, Forecast to 2025
- RnM2341294 |
- 17 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys.
Change in lifestyle and elevated stress levels have increased the prevalence of hypertension globally, thereby increasing the demand for hypertension drugs.
The global Hypertension Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hypertension Drug market based on company, product type, end user and key regions.
This report studies the global market size of Hypertension Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hypertension Drug in these regions.
This research report categorizes the global Hypertension Drug market by top players/brands, region, type and end user. This report also studies the global Hypertension Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lupin Limited
Novartis AG
Daiichi - Sankyo
Pfizer Inc
Ranbaxy Laboratories Limited
Sanofi S.A
AstraZeneca Plc
Johnson & Johnson Ltd
Boehringer Ingelheim
Merck & Co.
Market size by Product
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
Market size by End User
Hospital
Private clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hypertension Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hypertension Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hypertension Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hypertension Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hypertension Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hypertension Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Hypertension Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Hypertension Drug Market Size Growth Rate by Product
- 1.4.2 Calcium Channel Blockers
- 1.4.3 Diuretics
- 1.4.4 Beta Blockers Vasodilators
- 1.4.5 Angiotensin Converting Enzyme Inhibitors
- 1.4.6 Alpha Blockers
- 1.4.7 Angiotensin Receptor Blockers
- 1.4.8 Renin Inhibitors
- 1.5 Market by End User
- 1.5.1 Global Hypertension Drug Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Private clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Hypertension Drug Market Size
- 2.1.1 Global Hypertension Drug Revenue 2014-2025
- 2.1.2 Global Hypertension Drug Sales 2014-2025
- 2.2 Hypertension Drug Growth Rate by Regions
- 2.2.1 Global Hypertension Drug Sales by Regions
- 2.2.2 Global Hypertension Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Hypertension Drug Sales by Manufacturers
- 3.1.1 Hypertension Drug Sales by Manufacturers
- 3.1.2 Hypertension Drug Sales Market Share by Manufacturers
- 3.1.3 Global Hypertension Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Hypertension Drug Revenue by Manufacturers
- 3.2.1 Hypertension Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Hypertension Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Hypertension Drug Price by Manufacturers
- 3.4 Hypertension Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Hypertension Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hypertension Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Hypertension Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Hypertension Drug Sales by Product
- 4.2 Global Hypertension Drug Revenue by Product
- 4.3 Hypertension Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Hypertension Drug Breakdown Data by End User
6 North America
- 6.1 North America Hypertension Drug by Countries
- 6.1.1 North America Hypertension Drug Sales by Countries
- 6.1.2 North America Hypertension Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Hypertension Drug by Product
- 6.3 North America Hypertension Drug by End User
7 Europe
- 7.1 Europe Hypertension Drug by Countries
- 7.1.1 Europe Hypertension Drug Sales by Countries
- 7.1.2 Europe Hypertension Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hypertension Drug by Product
- 7.3 Europe Hypertension Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Hypertension Drug by Countries
- 8.1.1 Asia Pacific Hypertension Drug Sales by Countries
- 8.1.2 Asia Pacific Hypertension Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Hypertension Drug by Product
- 8.3 Asia Pacific Hypertension Drug by End User
9 Central & South America
- 9.1 Central & South America Hypertension Drug by Countries
- 9.1.1 Central & South America Hypertension Drug Sales by Countries
- 9.1.2 Central & South America Hypertension Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Hypertension Drug by Product
- 9.3 Central & South America Hypertension Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Hypertension Drug by Countries
- 10.1.1 Middle East and Africa Hypertension Drug Sales by Countries
- 10.1.2 Middle East and Africa Hypertension Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Hypertension Drug by Product
- 10.3 Middle East and Africa Hypertension Drug by End User
11 Company Profiles
- 11.1 Lupin Limited
- 11.1.1 Lupin Limited Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Lupin Limited Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Lupin Limited Hypertension Drug Products Offered
- 11.1.5 Lupin Limited Recent Development
- 11.2 Novartis AG
- 11.2.1 Novartis AG Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis AG Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis AG Hypertension Drug Products Offered
- 11.2.5 Novartis AG Recent Development
- 11.3 Daiichi - Sankyo
- 11.3.1 Daiichi - Sankyo Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Daiichi - Sankyo Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Daiichi - Sankyo Hypertension Drug Products Offered
- 11.3.5 Daiichi - Sankyo Recent Development
- 11.4 Pfizer Inc
- 11.4.1 Pfizer Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Inc Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Inc Hypertension Drug Products Offered
- 11.4.5 Pfizer Inc Recent Development
- 11.5 Ranbaxy Laboratories Limited
- 11.5.1 Ranbaxy Laboratories Limited Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Ranbaxy Laboratories Limited Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Ranbaxy Laboratories Limited Hypertension Drug Products Offered
- 11.5.5 Ranbaxy Laboratories Limited Recent Development
- 11.6 Sanofi S.A
- 11.6.1 Sanofi S.A Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sanofi S.A Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sanofi S.A Hypertension Drug Products Offered
- 11.6.5 Sanofi S.A Recent Development
- 11.7 AstraZeneca Plc
- 11.7.1 AstraZeneca Plc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 AstraZeneca Plc Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 AstraZeneca Plc Hypertension Drug Products Offered
- 11.7.5 AstraZeneca Plc Recent Development
- 11.8 Johnson & Johnson Ltd
- 11.8.1 Johnson & Johnson Ltd Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Johnson & Johnson Ltd Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Johnson & Johnson Ltd Hypertension Drug Products Offered
- 11.8.5 Johnson & Johnson Ltd Recent Development
- 11.9 Boehringer Ingelheim
- 11.9.1 Boehringer Ingelheim Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Boehringer Ingelheim Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Boehringer Ingelheim Hypertension Drug Products Offered
- 11.9.5 Boehringer Ingelheim Recent Development
- 11.10 Merck & Co.
- 11.10.1 Merck & Co. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Merck & Co. Hypertension Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Merck & Co. Hypertension Drug Products Offered
- 11.10.5 Merck & Co. Recent Development
12 Future Forecast
- 12.1 Hypertension Drug Market Forecast by Regions
- 12.1.1 Global Hypertension Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Hypertension Drug Revenue Forecast by Regions 2019-2025
- 12.2 Hypertension Drug Market Forecast by Product
- 12.2.1 Global Hypertension Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Hypertension Drug Revenue Forecast by Product 2019-2025
- 12.3 Hypertension Drug Market Forecast by End User
- 12.4 North America Hypertension Drug Forecast
- 12.5 Europe Hypertension Drug Forecast
- 12.6 Asia Pacific Hypertension Drug Forecast
- 12.7 Central & South America Hypertension Drug Forecast
- 12.8 Middle East and Africa Hypertension Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hypertension Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Hypertension Drug . Industry analysis & Market Report on Hypertension Drug is a syndicated market report, published as Global Hypertension Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hypertension Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
